Jura Health

Name

Jura Health

Legal name

Jura Health US Inc.

Website

https://jura.health

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Rare Disease Genetic Diagnostics

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Whole genome sequencing
• Rare disease diagnostics
• Clinical genetic testing
• Genetic counseling services
• At-home DNA testing

Headquarters

HQ city

Denver

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure, Others

Revenue model

1. Whole Genome Sequencing Testing: One-time clinical WGS test delivered through the Emerge Platform. Cash-pay available in all 50 states. Medicaid reimbursement currently approved in Colorado and Louisiana, with plans to expand to additional states.
2. Standalone Genetic Counseling: A la carte genetic counseling sessions priced at $50 cash pay, including 30 minutes of live 1:1 conversation plus 30 days of asynchronous chat. Free genetic counseling is included with every Emerge test order.
3. Medicaid Reimbursement: Jura Health is an approved Medicaid provider in Colorado and Louisiana for suspected rare disease testing, enabling reimbursement through state Medicaid programs.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Jura Health provides comprehensive whole genome sequencing (WGS) via its Emerge™ Platform, combining at-home saliva sample collection, clinical sequencing through Broad Clinical Labs, multilingual on-demand genetic counseling in up to 50 languages, and personalized disease-specific next-steps resources (advocacy groups, clinical trials, insurance support). Results are delivered as clinical reports to physicians within 4–5 weeks, with optional Pharmacogenomics (PGx) and Nutrigenomics (NGx) reports and a free ACMG 84 actionable gene panel included with each test.

Product overview

Jura Health offers a unified platform architecture centered on the Emerge™ Platform, which combines at-home saliva-based whole genome sequencing (via the Emerge™ DNA Test) with integrated genetic counseling and personalized follow-up resources. The core offering includes multiple report modules: Whole Genome Sequencing Report, Genetic Counselor Clinical Summary, Emerge Next Steps Resources, Pharmacogenomics Report, and Nutrigenomics Report—all delivered through Broad Clinical Labs. Add-on services include Genetic Counseling Support sessions and the opt-in ACMG 84 panel available at no extra cost. Provider-focused Payer Resources are also offered to support reimbursement workflows.

Differentiator

Problem solved

Functional benefit

Brands

• Emerge Platform: Whole genome sequencing and analysis platform with on-demand multilingual genetic counseling and disease-specific next steps support.

Products and services

• Emerge™ Platform An end-to-end health platform that combines at-home saliva sample collection, whole genome sequencing via Broad Clinical Labs, multilingual on-demand genetic counseling in 50 languages, and disease-specific next-steps resources (advocacy groups, clinical trials, insurance support) for patients and families facing rare or undiagnosed diseases.
• Emerge™ DNA Test An at-home saliva sample kit that sequences a patient's whole genome and delivers a full clinical report to the ordering physician within 4–5 weeks, designed to address the average 6-year diagnostic delay for rare diseases in children. Available cash-pay in all 50 states and reimbursed by Medicaid in Colorado and Louisiana.
• Standalone Genetic Counseling A standalone genetic counseling session priced at $50 cash pay, providing 30 minutes of live 1:1 conversation with a genetic counselor plus 30 days of asynchronous chat in 50 languages. Free genetic counseling is bundled with every Emerge DNA Test order.

Quantifiable outcome

• Reduces rare disease diagnostic timeline from 6 years to 5 weeks
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Startup Prize HealthcoreGTM or Marketing Partner · 26 February 2026Louisiana-based startup competition through which Jura Health participated and gained visibility, ultimately leading to its expansion to Louisiana. Founder Gregory Kallenberg described the expansion as evidence that the region is becoming a health innovation hub of national or international importance.
• Samba ScientificcoreStrategic or Co-development Partner · 14 November 2024Partnership to improve genomic testing access to underserved populations. Samba Scientific brings complementary capabilities in scientific outreach and market access to expand Jura Health's reach in medically underserved communities.
• UGenome AIcoreTechnology or IntegrationCollaboration leveraging UGenome AI's genomic platform technology for rare disease patient diagnosis and personalized plans, including pharmacogenomic profiling. UGenome AI and Jura Health also partnered with Open Table to link DNA insights with community social support networks.
• Open TablecoreStrategic or Co-development Partner501(c)(3) nonprofit pioneering community-based relational and social capital solutions. Together with UGenome AI, the partnership addresses non-medical determinants of health for families facing rare disease diagnoses by linking DNA insights with community social support networks.
• Broad Clinical LabscoreTechnology or IntegrationCAP-accredited and CLIA-certified laboratory that powers Jura Health's whole genome sequencing. Broad Clinical Labs (BCL) powered some of the world's largest WGS projects including the Human Genome Project, providing Jura Health with validated clinical sequencing infrastructure.
• Innosphere VenturesminorStrategic or Co-development PartnerColorado-based life sciences incubator that supported Jura Health through its program, culminating in graduation from Innosphere's Life Sciences Incubator. Operating under a U.S. Economic Development Administration Build to Scale Grant, the program aims to catapult participating companies' concepts into market-ready solutions.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• GeneDx: GeneDx is a clinical genomics company specializing in rare disease and pediatric whole genome and exome sequencing, directly competing with Jura Health in WGS for undiagnosed children, with established payer relationships and a larger commercial footprint.
• Centogene: Centogene is a rare disease diagnostics company providing WGS, WES, and biochemical testing with multi-country rare disease registries, directly competing in the rare disease pediatric diagnostic market.
• Natera: Natera is a genetic testing company offering reproductive, oncology, and rare disease tests including whole genome and exome sequencing, overlapping directly with Jura's pediatric rare disease WGS use case.
• Invitae: Invitae (now part of Labcorp) provides comprehensive genetic testing including WGS and rare disease panels, directly competing in the same clinical genomics category as Jura Health with much broader payer coverage.
• Ambry Genetics: Ambry Genetics (a Konica Minolta company) is a clinical genetic testing lab offering exome and genome sequencing for rare and hereditary disease, a directly comparable WGS provider competing for the same pediatric rare disease market.
• BillionToOne: BillionToOne is a precision diagnostics company using NGS for reproductive health and oncology, with comparable molecular diagnostics technology and a similar focus on accessible, high-sensitivity genetic testing.
• PreventionGenetics: PreventionGenetics (now part of Exact Sciences) is a CLIA-certified clinical DNA testing laboratory offering whole genome and exome sequencing services, directly comparable in technology and clinical use case to Jura's WGS offering.

Emerging players

• 3billion: 3billion is a rare disease genetic testing company offering whole exome and genome sequencing with AI-driven interpretation, focused on shortening the rare disease diagnostic odyssey, a directly comparable value proposition to Jura Health.

Broad incumbents

• Tempus AI: Tempus is a precision medicine company using AI and genomic sequencing across oncology and rare disease, with broader portfolio offerings but overlapping WGS/NGS technology and rare disease focus.
• Myriad Genetics: Myriad Genetics is an established clinical genomics company offering hereditary cancer, pharmacogenomic, and rare disease testing, providing overlapping capabilities as a broad incumbent in the genetic testing space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/jura-health
• Instagraminstagram.com/jurahealth

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jura Health